Abstract:Genetic research has identified a large number of genetic variants, both rare and common, underlying neurodevelopmental disorders (NDD) and major psychiatric disorders. Currently, these findings are being translated into clinical practice. However, there is a lack of knowledge and guidelines for psychiatric genetic testing (PsychGT) and genetic counseling (PsychGC). The European Union-funded COST action EnGagE (CA17130) network was started to investigate the current implementation status of PsychGT and PsychGC across 35 participating European countries. Here, we present the results of a pan-European online survey in which we gathered the opinions, knowledge, and practices of a self-selected sample of professionals involved/interested in the field. We received answers from 181 respondents. The three main occupational categories were genetic counselor (21.0%), clinical geneticist (24.9%), and researcher (25.4%). Of all 181 respondents, 106 provide GC for any psychiatric disorder or NDD, corresponding to 58.6% of the whole group ranging from 43.2% in Central Eastern Europe to 66.1% in Western Europe. Overall, 65.2% of the respondents reported that genetic testing is offered to individuals with NDD, and 26.5% indicated the same for individuals with major psychiatric disorders. Only 22.1% of the respondents indicated that they have guidelines for PsychGT. Pharmacogenetic testing actionable for psychiatric disorders was offered by 15%. Interestingly, when genetic tests are fully covered by national health insurance, more genetic testing is provided for individuals with NDD but not those with major psychiatric disorders. Our qualitative analyses of responses highlight the lack of guidelines and knowledge on utilizing and using genetic tests and education and training as the major obstacles to implementation. Indeed, the existence of psychiatric genetic training courses was confirmed by only 11.6% of respondents. The question on the relevance of up-to-date education and training in psychiatric genetics on everyday related practice was highly relevant. We provide evidence that PsychGC and PsychGT are already in use across European countries, but there is a lack of guidelines and education. Harmonization of practice and development of guidelines for genetic counseling, testing, and training professionals would improve equality and access to quality care for individuals with psychiatric disorders within Europe.

Need for integration of genetic counselors in the Portuguese healthcare: Their added value from the medical geneticists perspective

Expanding the primary care workforce by integrating genetic counselors in multidisciplinary care teams

Disclosure of genetic risk to family members: A qualitative study on healthcare professionals' perceived roles and responsibilities

Lack of guidelines and translational knowledge is hindering the implementation of psychiatric genetic counseling and testing within Europe - A multi-professional survey study

Genetic counselling legislation and practice in cancer in EU Member States

Experiences of genetic counselors practicing in multiple languages: Progress and places for improvement

Integrating Genetic Services in the Philippine Public Health Delivery System: The Value of Networks

A profile of genetic counseling and testing in Chinese patients with gynecologic oncology: a nationwide survey of Chinese gynecologists

Thirty-year of genetic counselling education in Europe: a growing professional area

Becoming agents for genomic change: genetic counsellors' views of patient care and implementation influences when genomics is mainstreamed

Medical geneticists, genetic diseases and services in Brazil in the age of personalized medicine

Provision of genetic services in Europe: current practices and issues

General practitioners’ (GPs) experience, attitudes and needs on clinical genetic services: a systematic review

Australian healthcare professionals' perspectives on genetic counseling and genetic diagnosis in vascular anomalies

Towards equity & inclusion: a critical examination of genetic Counselling Education on Intersex Healthcare

Genetic counselling considerations with genetic/genomic testing in Neonatal and Pediatric Intensive Care Units: A scoping review

Exploring genetic counselors' interest and role in transitional care discussions for pediatric patients with neurodevelopmental conditions

"Protection for the public, better use of resources and clearer lines": Interviews with genetic counselors and their colleagues on the need for regulation in Quebec

Further defining the roles and impact of genetic counselors in the biotechnology and pharmaceutical industry

Measuring quality and value in genetic counseling: The current landscape and future directions

Genetic counselors' and community clinicians' implementation and perceived barriers to informed consent during pre‐test counseling for hereditary cancer risk